Delivery Order SPE2DB24D3013-SPE2DB25FFNHS
Award Date
7/15/25
Potential Completion Date
7/16/25
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication, with a ceiling value of $2,577.99 and a period of performance through July 2, 2025. The contract is a Firm Fixed Price, Delivery Order type and is not set aside for any specific business category. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract has a ceiling value of $9,439.32 and a performance period through July 9, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes treatment medication. The contract is a firm fixed-price delivery order with a ceiling value of $10,081.57 and a performance period ending on June 5, 2025. This contract is not set-aside and was competitively awarded....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes treatment medication. The contract is a Firm Fixed Price, non-set-aside award with a ceiling value of $7,753.22 and a period of performance through June 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract is a firm-fixed-price, non-set-aside delivery order with a ceiling value of $18,272.76 and a period of performance ending on June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract is a firm-fixed-price delivery order with a ceiling value of $14,200.68 and a period of performance through May 27, 2025. The contract was not set-aside and was open to full and open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes treatment medication. The contract is a firm fixed-price delivery order with a ceiling value of $3,908.33 and a period of performance through May 23, 2025. This award is not associated with a set-aside program. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes treatment medication, with a ceiling value of $7,437.02. The contract is a firm-fixed-price delivery order, with a performance period ending on June 5, 2025. The contract is not set aside for any specific business category....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract has a ceiling value of $34,251.37 and is a firm fixed-price delivery order with a completion date of June 10, 2025. The contract is not set aside and is open to full and open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract has a ceiling value of $5,771.64 and runs through December 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...